Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar:41:244-246.
doi: 10.1016/j.ajem.2020.05.101. Epub 2020 Jun 2.

Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy

Saurabh Kumar  1 , Vinit Sharma  2 , Kanu Priya  3
Affiliations

Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy

Saurabh Kumar et al. Am J Emerg Med. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1
Fig. 1
Diagrammatic representation of CP therapy and its mode of action for treating COVID-19 patients. IgG antibodies from recovered patient could neutralize viral infection by blocking receptor-binding domain of COVID-19.
See this image and copyright information in PMC

References

    1. Ko J.H., Seok H., Cho S.Y., et al. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience. Antivir Ther. 2018;23(7):617–622. doi: 10.3851/IMP3243. - DOI - PubMed
    1. Hung I.F., To K.K., Lee C.K., et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis. 2011;52(4):447–456. doi: 10.1093/cid/ciq106. - DOI - PMC - PubMed
    1. Cheng Y., Wong R., Soo Y.O., et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24(1):44–46. doi: 10.1007/s10096-004-1271-9. - DOI - PMC - PubMed
    1. Zhang B., Liu S., Tan T., et al. Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection. Chest. 2020 doi: 10.1016/j.chest.2020.03.039. - DOI - PMC - PubMed
    1. Mair-Jenkins J., Saavedra-Campos M., Baillie J.K., et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015;211(1):80–90. doi: 10.1093/infdis/jiu396. - DOI - PMC - PubMed